Global transmucosal drugs market to be valued at $28b by 2032 | Healthcare Asia Magazine
Photo from Envato

Global transmucosal drugs market to be valued at $28b by 2032

Thanks to the rising prevalence of chronic conditions.

The global transmucosal drugs market is projected to reach $28b by 2032 at a compound annual growth rate of 7%, said DelveInsight.

The sector’s expansion is attributed to the rising prevalence of chronic conditions like cardiovascular disease.

Meanwhile, increasing adoption of these drugs, research and development efforts, and collaborations amongst major industry players are driving market growth.

“Innovations such as nanoparticles, liposomes, and microneedles are improving the efficiency and accuracy of drug delivery systems,” the report said.

Follow the link s for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Thomson Medical to open second fertility hub
The Singapore-based hospital operator has upgraded its hardware to meet patient needs.
Wearable tech is your heart’s new best friend
One specialist clinic in Singapore uses a Holter patch to cut face-to-face appointments.